Lupin Limited
Lupin Limited has informed the Exchange that the Company has entered into a License and Supply Agreement with Zentiva, a.s., for commercialization of Lupin s biosimilarCertolizumab Pegol. |SUBJECT: Arrangements for strategic, technical, manufacturing, or marketing tie up
Source link
